• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Info on Impax?

Anonymous

Guest
I am requesting info on Impax. There is an opening in my geography and the recruiter contacted me. I am a previous Ventiv employee needing to get back to work on my next contract. I am a little worried about just selling Zomig, which I think goes off patent shortly. Is there another drug in the immediate future? What is the environment like with Impax?
 




Zomig nasal will be around for a while. Leadership is weak. Pipeline is dead. Rytary is probably never going to be approved. Impax is looking good to be purchased and then you will out on the street again. Most are looking to get out. I would look elsewhere.